Platinum ineligibility in squamous cell carcinoma of the head and neck: consensus from Central America and the Caribbean

被引：1
作者：
Alvarado-Munoz, Juan F. [1 ]
Falco, Agustin [2 ]
Morales, Agatha R. [1 ]
Sanchez, Noe C. [3 ]
Reynoso, Giovanni [3 ]
Barillas, Allan [3 ]
Moreno, Jairo [4 ]
Lopez, Kreilin [5 ]
Prestol, Rogelio [5 ]
Cabreja, Angela [6 ]
Nunez, Cesar [6 ]
机构：
[1] Roosevelt Hosp, Guatemala City, Guatemala
[2] Alexander Fleming Inst Oncol, Buenos Aires, DF, Argentina
[3] Guatemalan Social Secur Inst, Guatemala City, Guatemala
[4] Natl Police Hosp, Managua, Nicaragua
[5] Heriberto Pieter Canc Inst, Santo Domingo, Dominican Rep
[6] Reg Oncol Inst Cibao, Santiago Los Caballeros, Dominican Rep
来源：
FUTURE ONCOLOGY | 2021年 / 17卷 / 15期
关键词：
cetuximab; Cisplatin; head and neck cancer; platinum toxicity; LOCALLY ADVANCED HEAD; CISPLATIN-INDUCED NEPHROTOXICITY; QUALITY-OF-LIFE; WEIGHT-LOSS; ELDERLY-PATIENTS; AIR-POLLUTION; HEARING-LOSS; LUNG-CANCER; RADIOTHERAPY; CONCURRENT;
D O I：
10.2217/fon-2020-0931
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The high incidence of head and neck cancer in Central America and the Caribbean, together with limitations in the healthcare system for patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) in this region necessitate a consensus of opinion based on a review of the literature on therapy with cisplatin plus radiation. Such an approach will ensure appropriate selection of patients who can benefit from therapy and reduce the incidence of related adverse events. Therefore, we recorded the opinion of experts in the region in order to identify needs and challenges in the treatment of LA SCCHN.
引用
收藏
页码：1963 / 1971
页数：9
相关论文
共 50 条
  • [41] Cetuximab A Review of its Use in Squamous Cell Carcinoma of the Head and Neck
    Frampton, James E.
    DRUGS, 2010, 70 (15) : 1987 - 2010
  • [42] Economic Analyses in Squamous Cell Carcinoma of the Head and Neck: A Review of the Literature From a Clinical Perspective
    de Souza, Jonas A.
    Santana, Iuri A.
    de Castro, Gilberto, Jr.
    Lopes, Gilberto de Lima, Jr.
    Shih, Ya-Chen Tina
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (05): : 989 - 996
  • [43] KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma
    Jiffar, T.
    Yilmaz, T.
    Lee, J.
    Hanna, E.
    El-Naggar, A.
    Yu, D.
    Myers, J. N.
    Kupferman, M. E.
    ONCOGENE, 2011, 30 (28) : 3163 - 3173
  • [44] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Cho, Byoung Chul
    Keum, Ki Chang
    Shin, Sang Joon
    Choi, Hye Jin
    Lee, Young Joo
    Kim, Se Hun
    Choi, Eun Chang
    Kim, Joo Hang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 27 - 32
  • [45] In squamous cell head and neck cancer: which platinum, how much and how often?
    Nwizu, Tobenna
    Adelstein, David J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (09) : 1033 - 1039
  • [46] Intracardiac metastasis from head and neck squamous cell carcinoma
    Abu Khalaf, Suha
    Riaz, Talha
    Mansour, Abdallah
    Doll, Donald
    BMJ CASE REPORTS, 2020, 13 (06)
  • [47] Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck
    Prabhash, Kumar
    Babu, Govind
    Chaturvedi, Pankaj
    Kuriakose, Moni
    Birur, Praveen
    Anand, Anil K.
    Kaushal, Ashish
    Mahajan, Abhishek
    Syiemlieh, Judita
    Singhal, Manish
    Gairola, Munish
    Ramachandra, Prakash
    Goyal, Sumit
    John, Subashini
    Nayyar, Rohit
    Patil, Vijay M.
    Rao, Vishal
    Roshan, Vikas
    Rath, G. K.
    INDIAN JOURNAL OF CANCER, 2020, 57 (05) : 1 - 5
  • [48] Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Parikh, Purvish M.
    Biswas, Ghanashyam
    Dhamne, Nilesh Ashok
    Deshmukh, Chetan Dilip
    Limaye, Sewanti
    Singh, Ashish
    Malhotra, Hemant
    Maniar, Viashsta Pankaj
    Kapur, Bhupendra Nath
    Sripada, Prasad V. S. S.
    Talreja, Vikas Tulsidas
    Patil, Poonam
    Agre, Suhas Vilasrao
    Bhat, Amit Dilip
    Nayak, Priya Privadarshini
    Seshachalam, Arun
    Dhabhar, Boman Nariman
    Sharma, Ajay
    Bhatt, Niraj N.
    Das, Pratap Kishore
    Sharma, Atul
    Kanakasetty, Govind Babu
    Advani, Suresh Hariram
    SOUTH ASIAN JOURNAL OF CANCER, 2025, 14 (01) : 90 - 102
  • [49] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [50] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81
12345